- Home
- IART
IART
Integra LifeSciences Holdings Corporation
as 03-25-2025 10:42am EST
| Founded: | 1989 | Country: | United States |
| Employees: | N/A | City: | PRINCETON |
| Market Cap: | N/A | IPO Year: | 1995 |
| Target Price: | $24.67 | AVG Volume (30 days): | 780.7K |
| Analyst Decision: | Sell | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.09 | EPS Growth: | N/A |
| 52 Week Low/High: | $16.81 - $35.49 | Next Earning Date: | 05-05-2025 |
| Revenue: | $1,610,527,000 | Revenue Growth: | 4.47% |
| Revenue Growth (this year): | 6.49% | Revenue Growth (next year): | 4.49% |
Latest Integra LifeSciences Holdings Corporation News
IART Breaking Stock News: Dive into IART Ticker-Specific Updates for Smart Investing
StockStory
2 days ago
Q4 Earnings Review: Surgical Equipment & Consumables - Specialty Stocks Led by Intuitive Surgical (NASDAQ:ISRG)
StockStory
8 days ago
3 Value Stocks in the Doghouse
StockStory
12 days ago
3 Reasons IART is Risky and 1 Stock to Buy Instead
GlobeNewswire
13 days ago
Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
StockStory
19 days ago
3 Small-Cap Stocks in the Doghouse
Zacks
23 days ago
Integra Q4 Earnings Beat Estimates, Revenues Rise Y/Y, Stock Up
GuruFocus.com
a month ago
Integra Lifesciences Holdings Corp (IART) Q4 2024 Earnings Call Highlights: Strong Revenue ...
Thomson Reuters StreetEvents
a month ago
Q4 2024 Integra Lifesciences Holdings Corp Earnings Call
Compare IART vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IART Integra LifeSciences Holdings Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.